FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Prins

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Geographic Areas

Netherlands

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Olivier Richel; Carel J M van Noesel; Henry J C de Vries; Marcel GW Dijkgraaf; Jan M Prins
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Marlous L Grijsen; Paul Lips; Maria Prins; Peter Reiss; Ineke G Stolte; Saskia M E Vrouenraets; Ferdinand W N M Wit; Jan M Prins
Low bone mineral density, regardless of HIV status, in men who have sex with men.
Amy Matser; Jan M Prins; Maria Prins; Maarten F Schim van der Loeff; Joost Vanhommerig; Henry J C de Vries; Ronald B Geskus; Sylvia M Bruisten
HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Prins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Olivier Richel; Carel J M van Noesel; Henry J C de Vries; Marcel GW Dijkgraaf; Jan M Prins
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
The lancet oncology 2013;14(4):346-53.
2013: Marlous L Grijsen; Paul Lips; Maria Prins; Peter Reiss; Ineke G Stolte; Saskia M E Vrouenraets; Ferdinand W N M Wit; Jan M Prins
Low bone mineral density, regardless of HIV status, in men who have sex with men.
The Journal of infectious diseases 2013;207(3):386-91.
2013: Amy Matser; Jan M Prins; Maria Prins; Maarten F Schim van der Loeff; Joost Vanhommerig; Henry J C de Vries; Ronald B Geskus; Sylvia M Bruisten
HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infection.
PloS one 2013;8(3):e57740.
2012: Marlous L Grijsen; Rebecca Holman; Selwyn H Lowe; Kees Brinkman; Frank de Wolf; Luuk Gras; Ferdinand W N M Wit; Jan M Prins
Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infection.
AIDS (London, England) 2012;26(15):1974-7.
2012: I Marion Sumari-de Boer; Jan M Prins; Mirjam A G Sprangers; Pythia T Nieuwkerk
HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients.
AIDS and behavior 2012;16(6):1681-9.
2012: Shuangjie Zhang; Clemens Richter; Colette Smit; Ard I van Sighem; Frank de Wolf; Luuk Gras; Robert Kauffmann; Anouk Kesselring; Jan M Prins; Peter Reiss
Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2012;60(3):265-72.
2012: Mariëlle A J Beerepoot; Corianne A J M de Borgie; Theo M de Reijke; Jeanne Koeijers; Sita Nys; Jan M Prins; Ellen Stobberingh; Gerben ter Riet; Willem M van der Wal; Annelies Verbon; Suzanne E Geerlings
Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
Archives of internal medicine 2012;172(9):704-12.
2012: Ingrid H M Friesema; Leslie D Isken; Marion Koopmans; Adam Meijer; Jan M Prins; Janko van Beek; Mariken van der Lubben; Marianne A B van der Sande; Rianne van Gageldonk-Lafeber; Simone Boskamp; Menno D De Jong; Gé A Donker
Course of pandemic influenza A(H1N1) 2009 virus infection in Dutch patients.
Influenza and other respiratory viruses 2012;6(3):e16-20.
2012: M A J Beerepoot; C D J den Heijer; J Penders; Jan M Prins; E E Stobberingh; Suzanne E Geerlings
Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012;18(4):E84-90.
2012: Marlies Heiligenberg; Roel Coutinho; Henry J C de Vries; Suzanne E Geerlings; Maria Prins; Arjen G C L Speksnijder; Maarten F Schim van der Loeff; Jan M Prins
Low prevalence of asymptomatic sexually transmitted infections in HIV-infected heterosexuals visiting an HIV clinic in the Netherlands.
AIDS (London, England) 2012;26(5):646-9.
2012: W J Wiersinga; R M Aleva; W G Boersma; Marc J M Bonten; J E Degener; R Janknegt; R E Jonkers; Bart Jan Kullberg; Jan M Prins; A P E Sachs; Jeroen A Schouten; T J Verheij
SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults.
The Netherlands journal of medicine 2012;70(2):90-101.
2012: Willem Joost Wiersinga; Jan M Prins; Diederik van de Beek
Therapy-resistant opsoclonus-myoclonus syndrome secondary to HIV-1 infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(3):447-8.
2012: Marlous L Grijsen; Andy I M Hoepelman; Rebecca Holman; Jan M Prins; Guido E van den Berk; Ferdinand W N M Wit; Frank de Wolf; Luuk Gras
No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia.
Antiviral therapy 2012;17(8):1609-13.
2012: Marlies Heiligenberg; Henry J C de Vries; Han S A Fennema; Suzanne E Geerlings; Maria Prins; Bart Rijnders; Maarten F Schim van der Loeff; Willem I van der Meijden; Jan M Prins
High prevalence of sexually transmitted infections in HIV-infected men during routine outpatient visits in the Netherlands.
Sexually transmitted diseases 2012;39(1):8-15.
2011: Mariëlle A J Beerepoot; Corianne A J M de Borgie; Theo M de Reijke; Jeanne Koeijers; Sita Nys; Jan M Prins; Ellen Stobberingh; Gerben ter Riet; Willem M van der Wal; Annelies Verbon; Suzanne E Geerlings
Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
Archives of internal medicine 2011;171(14):1270-8.
2011: Matthijs C Brouwer; Jan M Prins; Lodewijk Spanjaard; Diederik van de Beek; Peter van der Ley; Arie van der Ende
Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide.
The Journal of infection 2011;62(6):479-83.
2011: I Marion de Boer; Jan M Prins; Colette Smit; Mirjam A G Sprangers; Pythia T Nieuwkerk
Self-reported symptoms among HIV-lnfected patients on highly active antiretroviral therapy in the ATHENA cohort in The Netherlands.
HIV clinical trials 2011;12(3):161-70.
2011: Mireille Centlivre; Nicolas Legrand; Radjin Steingrover; Renee van der Sluis; Marlous L Grijsen; Margreet Bakker; Suzanne Jurriaans; Ben Berkhout; William A Paxton; Jan M Prins; Georgios Pollakis
Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection.
Journal of leukocyte biology 2011;89(5):785-95.
2011: A H W Bruns; M C Cucciolillo; R El Moussaoui; R H H Groenwold; Jan Jelrik Oosterheert; Jan M Prins; A I M Hoepelman
Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2011;17(5):763-8.
2011: Paul J Nederkoorn; Willeke F Westendorp; Imke J Hooijenga; Rob J De Haan; Diederik W J Dippel; Frederique H Vermeij; Marcel GW Dijkgraaf; Jan M Prins; Lodewijk Spanjaard; Diederik van de Beek
Preventive antibiotics in stroke study: rationale and protocol for a randomised trial.
International journal of stroke : official journal of the International Stroke Society 2011;6(2):159-63.
2011: Sarah E Stutterheim; Iris Shiripinda; Arjan E R Bos; John B Pryor; Marijn de Bruin; Jeannine F J B Nellen; Gerjo Kok; Jan M Prins; Herman P Schaalma
HIV status disclosure among HIV-positive African and Afro-Caribbean people in the Netherlands.
AIDS care 2011;23(2):195-205.
2011: Merlijn A Kramer; Marion Cornelissen; Dimitrios Paraskevis; Maria Prins; Roel A Coutinho; Ard I van Sighem; Lesley Sabajo; Ashley J Duits; Cai N Winkel; Jan M Prins; Marchina E Van Der Ende; Robert H Kauffmann; E L M Op de Coul
HIV transmission patterns among The Netherlands, Suriname, and The Netherlands Antilles: a molecular epidemiological study.
AIDS research and human retroviruses 2011;27(2):123-30.
2010: I Marion de Boer; Jan M Prins; Mirjam A G Sprangers; Pythia T Nieuwkerk
Using different calculations of pharmacy refill adherence to predict virological failure among HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2010;55(5):635-40.
2010: Ingrid M M Schellens; Katalin Pogany; Geertje H A Westerlaken; José A M Borghans; Frank Miedema; Irene G M van Valkengoed; Frank P Kroon; Joep M A Lange; Kees Brinkman; Jan M Prins; Debbie Van Baarle
Immunological analysis of treatment interruption after early highly active antiretroviral therapy.
Viral immunology 2010;23(6):609-18.
2010: Theodora E M S de Vries-Sluijs; Jurriën G P Reijnders; Bettina E Hansen; Hans L Zaaijer; Jan M Prins; Suzan D Pas; Martin Schutten; Andy I M Hoepelman; Clemens Richter; Jan W Mulder; Robert A de Man; Harry L A Janssen; Marchina E Van Der Ende
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus.
Gastroenterology 2010;139(6):1934-41.
2010: O Richel; U Wieland; Henry J C de Vries; N H Brockmeyer; Carel J M van Noesel; A Potthoff; Jan M Prins; A Kreuter
Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men.
The British journal of dermatology 2010;163(6):1301-7.
2010: Gerard J B Sonder; Jan M Prins; Rosa M Regez; Kees Brinkman; Jan-Willem Mulder; J Veenstra; Frans A P Claessen; Anneke van den Hoek
Comparison of two HIV postexposure prophylaxis regimens among men who have sex with men in Amsterdam: adverse effects do not influence compliance.
Sexually transmitted diseases 2010;37(11):681-6.
2010: A Verbon; Jan M Prins
Shoulder pain in two HIV-seropositive patients. Avascular necrosis (AVN) of the bone.
The Netherlands journal of medicine 2010;68(10):322-5.
2010: Marlous L Grijsen; Saskia M E Vrouenraets; Radjin Steingrover; Paul Lips; Peter Reiss; Ferdinand W N M Wit; Jan M Prins
High prevalence of reduced bone mineral density in primary HIV-1-infected men.
AIDS (London, England) 2010;24(14):2233-8.
2010: Radjin Steingrover; Evian Fernandez Garcia; Irene G M van Valkengoed; Vincent Bekker; Daniela Bezemer; Frank P Kroon; Lukas R C Dekker; Maria Prins; Frank de Wolf; Joep M A Lange; Jan M Prins
Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection.
AIDS research and human retroviruses 2010;26(4):379-87.
2010: Anke H W Bruns; Jan Jelrik Oosterheert; Rachida El Moussaoui; Brent C Opmeer; Andy I M Hoepelman; Jan M Prins
Pneumonia recovery: discrepancies in perspectives of the radiologist, physician and patient.
Journal of general internal medicine 2010;25(3):203-6.
2010: I Marion de Boer-van der Kolk; Mirjam A G Sprangers; Jan M Prins; Colette Smit; Frank de Wolf; Pythia T Nieuwkerk
Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(2):255-63.
2010: Pythia T Nieuwkerk; I Marion de Boer-van der Kolk; Jan M Prins; Mirjam Locadia; Mirjam A G Sprangers
Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding.
Antiviral therapy 2010;15(6):913-6.
2009: Jerome Lindeboom; Robert Lindeboom; Elisabeth S Bruijnesteijn van Coppenraet; Ed J Kuijper; Jacco Tuk; Jan M Prins
Esthetic outcome of surgical excision versus antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis in children.
The Pediatric infectious disease journal 2009;28(11):1028-30.
2009: E van Leeuwen; Sjoerd Repping; Jan M Prins; Peter Reiss; Fulco van der Veen
Assisted reproductive technologies to establish pregnancies in couples with an HIV-1-infected man.
The Netherlands journal of medicine 2009;67(8):322-7.
2009: Diederik van de Beek; Eelco F M Wijdicks; Frederique H Vermeij; Rob J De Haan; Jan M Prins; Lodewijk Spanjaard; Diederik W J Dippel; Paul J Nederkoorn
Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis.
Archives of neurology 2009;66(9):1076-81.
2009: Jeannine F J B Nellen; Pythia T Nieuwkerk; David M Burger; Mirte Wibaut; Luuk A Gras; Jan M Prins
Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?
AIDS care 2009;21(7):842-50.
2009: Antoinette C van der Kuyl; Fokla Zorgdrager; Suzanne Jurriaans; Nicole Back; Jan M Prins; Kees Brinkman; Arne van Eeden; Margreet Bakker; Marion Cornelissen
Incidence of human immunodeficiency virus type 1 dual infections in Amsterdam, The Netherlands, during 2003-2007.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(7):973-8.
2009: Alexander O. Pasternak; Suzanne Jurriaans; Margreet Bakker; Jan M Prins; Ben Berkhout; Vladimir V Lukashov
Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome.
PloS one 2009;4(12):e8490.
2008: Jerome Lindeboom; Elisabeth S Bruijnesteijn van Coppenraet; Ed J Kuijper; Roger M Polsbroek; Roy B Horsthuis; Jan M Prins; Robert Lindeboom
Interpretation and precision of the Observer Scar Assessment Scale improved by a revised scoring.
Journal of clinical epidemiology 2008;61(12):1289-95.
2008: Jan M Prins; J E Degener; A J de Neeling; I C Gyssens
Experiences with the Dutch Working Party on antibiotic policy (SWAB).
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2008;13(46):.
2008: Sanjay U C Sankatsing; Jan M Prins; Si-La Yong; Jeroen Roelofsen; André B P van Kuilenburg; Steve Kewn; David J Back; Frederike J Bemelman; Ineke J M ten Berge
Mycophenolate mofetil inhibits T-cell proliferation in kidney transplant recipients without lowering intracellular dGTP and GTP.
Transplant international : official journal of the European Society for Organ Transplantation 2008;21(11):1066-71.
2008: B M Roede; Paul Bresser; Patrick J E Bindels; A Kok; M Prins; Gerben ter Riet; R B Geskus; Ron Herings; Jan M Prins
Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study.
Thorax 2008;63(11):968-73.
2008: Elisabeth van Leeuwen; Ferdinand W Wit; Jan M Prins; Peter Reiss; Fulco van der Veen; Sjoerd Repping
Semen quality remains stable during 96 weeks of untreated human immunodeficiency virus-1 infection.
Fertility and sterility 2008;90(3):636-41.
2008: Jan M Prins; Richard P Koopmans
[Novel side effects of moxifloxacin: making a balanced decision again].
Nederlands tijdschrift voor geneeskunde 2008;152(34):1862-4.
2008: Radjin Steingrover; Katalyn Pogány; Evian Fernandez Garcia; Suzanne Jurriaans; Kees Brinkman; Hanneke Schuitemaker; Frank Miedema; Joep M A Lange; Jan M Prins
HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
AIDS (London, England) 2008;22(13):1583-8.
2008: Elisabeth van Leeuwen; Marja Visser; Jan M Prins; Pythia T Nieuwkerk; Fulco van der Veen
HIV couples' anxiety and risk taking during ART.
Fertility and sterility 2008;90(2):456-8.
2008: Nienke Vrisekoop; Rogier van Gent; Anne Bregje de Boer; Sigrid A Otto; Jan C C Borleffs; Radjin Steingrover; Jan M Prins; Taco W Kuijpers; Tom F W Wolfs; Sibyl P M Geelen; Irma Vulto; Peter Lansdorp; kiki tesselaar; José A M Borghans; Frank Miedema
Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(2):1573-81.
2008: Rachida el Moussaoui; B M Roede; Peter Speelman; Paul Bresser; Jan M Prins; Patrick Bossuyt
Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
Thorax 2008;63(5):415-22.
2008: Jeannine F J B Nellen; M Damming; M H Godfried; Kees Boer; M E van der Ende; David Burger; Frank de Wolf; Ferdinand W N M Wit; Jan M Prins
Steady-state nevirapine plasma concentrations are influenced by pregnancy.
HIV medicine 2008;9(4):234-8.
2008: Elisabeth van Leeuwen; Ferdinand W N M Wit; Sjoerd Repping; Jan Karel M Eeftinck Schattenkerk; Peter Reiss; Fulco van der Veen; Jan M Prins
Effects of antiretroviral therapy on semen quality.
AIDS (London, England) 2008;22(5):637-42.
2008: H S Hermanides; Marlies E J L Hulscher; Jeroen A Schouten; Jan M Prins; Suzanne E Geerlings
Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(5):703-11.
2008: Jan Jelrik Oosterheert; Marc J M Bonten; M M E Schneider; Erik Buskens; Jan-Willem J Lammers; W N M Hustinx; Mark H H Kramer; Jan M Prins; Peter Slee; Karin A H Kaasjager; Ilja M Hoepelman
[An early switch from intravenous to oral antibiotics is equally effective as the standard intravenous therapy in severe community acquired pneumonia].
Nederlands tijdschrift voor geneeskunde 2008;152(5):269-74.
2008: Suzanne Jurriaans; Karolina Kozaczynska; Fokla Zorgdrager; Radjin Steingrover; Jan M Prins; Antoinette C van der Kuyl; Marion Cornelissen
A sudden rise in viral load is infrequently associated with HIV-1 superinfection.
Journal of acquired immune deficiency syndromes (1999) 2008;47(1):69-73.
2007: Joost N Vermeulen; Jan M Prins; Evelien Bunnik; C Erik Hack; Suzanne Jurriaans; Frank Miedema; Joep M A Lange; Hanneke Schuitemaker
Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals.
AIDS research and human retroviruses 2007;23(11):1348-53.
2007: Brent C Opmeer; Rachida el Moussaoui; Patrick Bossuyt; Peter Speelman; Jan M Prins; Corianne De Borgie
Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia.
The Journal of antimicrobial chemotherapy 2007;60(5):1131-6.
2007: Selwyn H Lowe; Elisabeth van Leeuwen; Jacqueline A H Droste; Fulco van der Veen; Peter Reiss; Joep M A Lange; David Burger; Sjoerd Repping; Jan M Prins
Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen.
Therapeutic drug monitoring 2007;29(5):566-70.
2007: Gerard J B Sonder; Anneke van den Hoek; Rosa M Regez; Kees Brinkman; Jan M Prins; Jan-Willem Mulder; Jan Veenstra; Frans A Claessen; Roel A Coutinho
Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004.
Sexually transmitted diseases 2007;34(5):288-93.
2007: Marion Cornelissen; Suzanne Jurriaans; Karolina Kozaczynska; Jan M Prins; Raditijo A Hamidjaja; Fokla Zorgdrager; Margreet Bakker; Nicole Back; Antoinette C van der Kuyl
Routine HIV-1 genotyping as a tool to identify dual infections.
AIDS (London, England) 2007;21(7):807-11.
2007: Jerome Lindeboom; Ed J Kuijper; Elisabeth S Bruijnesteijn van Coppenraet; Robert Lindeboom; Jan M Prins
Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(8):1057-64.
2007: Katalin Pogány; Irene G M van Valkengoed; Irene G Vanvalkengoed; Jan M Prins; Pythia T Nieuwkerk; Ineke van der Ende; Robbert H Kauffmann; Frank P Kroon; Annelies Verbon; Marianne F Nievaard; Joep M A Lange; Kees Brinkman
Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN).
Journal of acquired immune deficiency syndromes (1999) 2007;44(4):395-400.
2007: B M Roede; Paul Bresser; Rachida el Moussaoui; Frans H Krouwels; B T J van den Berg; P M Hooghiemstra; Corianne De Borgie; Peter Speelman; Patrick Bossuyt; Jan M Prins
Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2007;13(3):284-90.
2007: Sanjay U C Sankatsing; Marion Cornelissen; Nico Kloosterboer; Kristel M L Crommentuyn; Tessa M Bosch; Frederik P Mul; Suzanne Jurriaans; Alwin D R Huitema; Jos H Beijnen; Joep M A Lange; Jan M Prins; Hanneke Schuitemaker
Antiviral activity of HIV type 1 protease inhibitors nelfinavir and indinavir in vivo is not influenced by P-glycoprotein activity on CD4+ T cells.
AIDS research and human retroviruses 2007;23(1):19-27.
2007: E van Leeuwen; R Ter Heine; F van der Veen; Sjoerd Repping; Jos H Beijnen; Jan M Prins
Penetration of atazanavir in seminal plasma of men infected with human immunodeficiency virus type 1.
Antimicrobial agents and chemotherapy 2007;51(1):335-7.
2006: Jerome Lindeboom; Ed J Kuijper; Jan M Prins; Elisabeth S Bruijnesteijn van Coppenraet; Robert Lindeboom
Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(12):1547-51.
2006: Jan Jelrik Oosterheert; Marc J M Bonten; M M E Schneider; Erik Buskens; Jan-Willem J Lammers; Willem M N Hustinx; Mark H H Kramer; Jan M Prins; Peter Slee; Karin A H Kaasjager; Andy I M Hoepelman
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
BMJ (Clinical research ed.) 2006;333(7580):1193.
2006: Selwyn H Lowe; Jori Symons; Jacqueline A H Droste; Reinier W Ten Kate; Suzanne Jurriaans; David Burger; Jan C C Borleffs; Joep M A Lange; Jan M Prins
No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations.
HIV clinical trials 2006;7(6):285-90.
2006: S E Geerlings; Peterhans J Van den Broek; E P van Haarst; L J Vleming; K M A van Haaren; R Janknegt; G J Platenkamp; Jan M Prins
[Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections].
Nederlands tijdschrift voor geneeskunde 2006;150(43):2370-6.
2006: Rachida el Moussaoui; Brent C Opmeer; Corianne De Borgie; Pythia T Nieuwkerk; Patrick Bossuyt; Peter Speelman; Jan M Prins
Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.
Chest 2006;130(4):1165-72.
2006: Jerome Lindeboom; Anne M J B Smets; Ed J Kuijper; Rick van Rijn; Jan M Prins
The sonographic characteristics of nontuberculous mycobacterial cervicofacial lymphadenitis in children.
Pediatric radiology 2006;36(10):1063-7.
2006: Berendina M Roede; Patrick J E Bindels; Henk J Brouwer; Paul Bresser; Corianne De Borgie; Jan M Prins
Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines.
The British journal of general practice : the journal of the Royal College of General Practitioners 2006;56(530):662-5.
2006: Rachida el Moussaoui; Corianne De Borgie; Peterhans J Van den Broek; Willem N Hustinx; Paul Bresser; Guido E L van den Berk; Jan-Werner Poley; Bob van den Berg; Frans H Krouwels; Marc J M Bonten; Carla Weenink; Patrick Bossuyt; Peter Speelman; Brent C Opmeer; Jan M Prins
Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
BMJ (Clinical research ed.) 2006;332(7554):1355.
2006: Jerome Lindeboom; Ed J Kuijper; Elisabeth S Bruijnesteijn van Coppenraet; Jan M Prins
First case of an oculofacial lesion due to Mycobacterium haemophilum infection in an immunocompetent child.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2006;101(6):774-6.
2006: J C Bos; C Schultsz; Christina M.J.E, Vandenbroucke-Grauls; Peter Speelman; Jan M Prins
[Optimising antibiotic policies in the Netherlands. IX. SWAB guidelines for antimicrobial therapy in adults with acute infectious diarrhoea].
Nederlands tijdschrift voor geneeskunde 2006;150(20):1116-22.
2006: Guido E L van den Berk; L Arnold Noorduyn; Ruud J Van Ketel; Jeannouel van Leeuwen; Willem A Bemelman; Jan M Prins
A fatal pseudo-tumour: disseminated basidiobolomycosis.
BMC infectious diseases 2006;6():140.
2006: Mirjam Locadia; Rosa A van Grieken; Jan M Prins; Henry J C de Vries; Mirjam A G Sprangers; Pythia T Nieuwkerk
Patients' preferences regarding the timing of highly active antiretroviral therapy initiation for chronic asymptomatic HIV-1 infection.
Antiviral therapy 2006;11(3):335-41.
2006: Marion Cornelissen; Suzanne Jurriaans; Jan M Prins; Margreet Bakker; Antoinette C van der Kuyl
Absence of seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years undetectable plasma HIV-1 viral load.
AIDS research and therapy 2006;3():3.
2005: Nienke Vrisekoop; Sanjay U C Sankatsing; Christine A Jansen; Marijke Th L Roos; Sigrid A Otto; Hanneke Schuitemaker; Joep M A Lange; Jan M Prins; Frank Miedema
Short communication: No detrimental immunological effects of mycophenolate mofetil and HAART in treatment-naive acute and chronic HIV-1-infected patients.
AIDS research and human retroviruses 2005;21(12):991-6.
2005: Jerome Lindeboom; Jan M Prins; Elisabeth S Bruijnesteijn van Coppenraet; Robert Lindeboom; Ed J Kuijper
Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(11):1569-75.
2005: K Pogány; Hans L Zaaijer; Jan M Prins; Ferdinand W N M Wit; Joep M A Lange; Marcel G H M Beld
Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
AIDS research and human retroviruses 2005;21(11):922-6.
2005: Frank van Leth; Jan M Prins; Joep M A Lange; Suzanne E Geerlings
Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens.
AIDS (London, England) 2005;19(15):1722-3.
2005: Bregt S Kappelhoff; Alwin D R Huitema; Sanjay U C Sankatsing; Pieter L Meenhorst; Eric C M van Gorp; Jan W Mulder; Jan M Prins; Jos H Beijnen
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.
British journal of clinical pharmacology 2005;60(3):276-86.
2005: Christine A Jansen; Iris M De Cuyper; Radjin Steingrover; Suzanne Jurriaans; Sanjay U C Sankatsing; Jan M Prins; Joep M A Lange; Debbie Van Baarle; Frank Miedema
Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.
AIDS (London, England) 2005;19(11):1145-54.
2005: Gerard J B Sonder; Rosa M Regez; Kees Brinkman; Jan M Prins; Jan-Willem Mulder; Joke Spaargaren; Roel A Coutinho; Anneke van den Hoek
Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3.
BMJ (Clinical research ed.) 2005;330(7495):825-9.
2005: E van Leeuwen; Jan W A de Vries; Suzanne Jurriaans; Harold R Verhoeve; Jan M Prins; Sjoerd Repping; Fulco van der Veen
[Intra uterine insemination with processed sperm for HIV serodiscordant couples in whom the man is HIV positive].
Nederlands tijdschrift voor geneeskunde 2005;149(8):423-4.
2005: Ferdinand W N M Wit; Daniel H Blanckenberg; Kees Brinkman; Jan M Prins; Marchina E Van Der Ende; M M E Schneider; Jan W Mulder; Frank de Wolf; Joep Ma Lange
Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.
AIDS (London, England) 2005;19(3):345-8.
2005: Bregt S Kappelhoff; Alwin D R Huitema; Zeynep Yalvaç; Jan M Prins; Jan W Mulder; Pieter L Meenhorst; Jos H Beijnen
Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.
Clinical pharmacokinetics 2005;44(8):849-61.
2004: Selwyn H Lowe; Jan M Prins; Joep M A Lange
Antiretroviral therapy in previously untreated adults infected with the human immunodeficiency virus type I: established and potential determinants of virological outcome.
The Netherlands journal of medicine 2004;62(11):424-40.
2004: J F J B Nellen; Mieke H Godfried; M E Kreijenbroek; Henriëtte J Scherpbier; Jan M Prins; Kees Boer
[Treatment of HIV-1 infected pregnant women].
Nederlands tijdschrift voor geneeskunde 2004;148(41):2005-8.
2004: Sanjay U C Sankatsing; Suzanne Jurriaans; Peter van Swieten; Frank van Leth; Marion Cornelissen; Frank Miedema; Joep M A Lange; Hanneke Schuitemaker; Jan M Prins
Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.
AIDS (London, England) 2004;18(14):1925-31.
2004: Jeannine F J B Nellen; Igor Schillevoort; Ferdinand W N M Wit; Alina S Bergshoeff; Mieke H Godfried; Kees Boer; Joep M A Lange; David Burger; Jan M Prins
Nelfinavir plasma concentrations are low during pregnancy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(5):736-40.
2004: Monique M R de Maat; Jeannine F J B Nellen; Alwin D R Huitema; Ferdinand W N M Wit; Jan W Mulder; Jan M Prins; Jos H Beijnen
Race is not associated with nevirapine pharmacokinetics.
Therapeutic drug monitoring 2004;26(4):456-8.
2004: Jeannine F J B Nellen; Ferdinand W N M Wit; Frank de Wolf; Suzanne Jurriaans; Joep M A Lange; Jan M Prins
Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands.
Journal of acquired immune deficiency syndromes (1999) 2004;36(4):943-50.
2004: Suzanne Jurriaans; Sanjay U C Sankatsing; Jan M Prins; Hanneke Schuitemaker; Joep Lange; Antoinette C van der Kuyl; Marion Cornelissen
HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenolate mofetil.
AIDS (London, England) 2004;18(11):1607-8.
2004: Daniela Bezemer; Suzanne Jurriaans; Maria Prins; Lia van der Hoek; Jan M Prins; Frank de Wolf; Ben Berkhout; Roel A Coutinho; Nicole Back
Declining trend in transmission of drug-resistant HIV-1 in Amsterdam.
AIDS (London, England) 2004;18(11):1571-7.
2004: Selwyn H Lowe; Sanjay U C Sankatsing; Sjoerd Repping; Fulco van der Veen; Peter Reiss; Joep M A Lange; Jan M Prins
Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.
AIDS (London, England) 2004;18(10):1353-62.
2004: Rachida el Moussaoui; Brent C Opmeer; Patrick Bossuyt; Peter Speelman; Corianne De Borgie; Jan M Prins
Development and validation of a short questionnaire in community acquired pneumonia.
Thorax 2004;59(7):591-5.
2004: Elisabeth S Bruijnesteijn van Coppenraet; Jerome Lindeboom; Jan M Prins; M F Peeters; Eric C J Claas; Ed J Kuijper
Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children.
Journal of clinical microbiology 2004;42(6):2644-50.
2004: Sanjay U C Sankatsing; Jos H Beijnen; Alfred H Schinkel; Joep M A Lange; Jan M Prins
P glycoprotein in human immunodeficiency virus type 1 infection and therapy.
Antimicrobial agents and chemotherapy 2004;48(4):1073-81.
2004: René E Jonkers; Kamilla D Lettinga; T H Pels Rijcken; Jan M Prins; C M Roos; Otto M van Delden; Annelies Verbon; Paul Bresser; Henk M Jansen
Abnormal radiological findings and a decreased carbon monoxide transfer factor can persist long after the acute phase of Legionella pneumophila pneumonia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(5):605-11.
2004: Sanjay U C Sankatsing; Patrick G Hoggard; Alwin D R Huitema; Rolf W Sparidans; Stephen Kewn; Kristel M L Crommentuyn; Joep M A Lange; Jos H Beijnen; David J Back; Jan M Prins
Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.
Clinical pharmacokinetics 2004;43(12):823-32.
2003: Sanjay U C Sankatsing; Gerrit Jan Weverling; Monika Peeters; Gerben van't Klooster; Boris Gruzdev; Aza Rakhmanova; Sven A Danner; Suzanne Jurriaans; Jan M Prins; Joep M A Lange
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen.
AIDS (London, England) 2003;17(18):2623-7.
2003: M G A van Vonderen; J C Bos; Jan M Prins; P Wertheim-van Dillen; P Speelman
Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
The Netherlands journal of medicine 2003;61(7):238-41.
2003: Sanjay U C Sankatsing; Rieneke van Praag; Ronald P van Rij; Ronald Rientsma; Suzanne Jurriaans; Joep M A Lange; Jan M Prins; Hanneke Schuitemaker
Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.
Antiviral therapy 2003;8(2):137-42.
2003: Kamilla D Lettinga; Sebastiaan Weijer; Peter Speelman; Jan M Prins; Tom van der Poll; Annelies Verbon
Reduced interferon-gamma release in patients recovered from Legionnaires' disease.
Thorax 2003;58(1):63-7.
2002: Kamilla D Lettinga; Annelies Verbon; Gerrit Jan Weverling; J F P Schellekens; Jeroen W Den Boer; Ed P F Yzerman; Jacobus Prins; Wim G Boersma; Ruud J Van Ketel; Jan M Prins; Peter Speelman
Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy.
Emerging infectious diseases 2002;8(12):1448-54.
2002: Sanjay U C Sankatsing; Jacqueline A H Droste; David Burger; Rieneke van Praag; Suzanne Jurriaans; Joep M A Lange; Jan M Prins
Limited penetration of lopinavir into seminal plasma of HIV-1-infected men.
AIDS (London, England) 2002;16(12):1698-700.
2002: Selwyn H Lowe; Jan M Prins; Johannes van der Lelie; Joep M A Lange
Does highly active antiretroviral therapy induce sickle cell crises?
AIDS (London, England) 2002;16(11):1572-4.
2002: Kamilla D Lettinga; Annelies Verbon; Pythia T Nieuwkerk; René E Jonkers; Berthold P R Gersons; Jan M Prins; Peter Speelman
Health-related quality of life and posttraumatic stress disorder among survivors of an outbreak of Legionnaires disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(1):11-7.
2002: Anja U G van Lent; Joep F W M Bartelsman; G N J Tytgat; Peter Speelman; Jan M Prins
Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract.
Gastrointestinal endoscopy 2002;55(4):518-22.
2002: Gerard J B Sonder; Rosa M Regez; Kees Brinkman; Jan M Prins; Jan-Willem Mulder; Roel A Coutinho; J A R van den Hoek
[Post-exposure treatment against HIV outside of the hospital in Amsterdam, January-December 2000].
Nederlands tijdschrift voor geneeskunde 2002;146(13):629-33.
2002: Rieneke van Praag; Ferdinand W N M Wit; Suzanne Jurriaans; Frank de Wolf; Jan M Prins; Joep M A Lange
Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.
AIDS (London, England) 2002;16(5):719-25.
2002: Ronald P van Rij; Rieneke van Praag; Jan M Prins; Ronald Rientsma; Suzanne Jurriaans; Joep M A Lange; Hanneke Schuitemaker
Persistence of viral HLA-DR- CD4 T-cell reservoir during prolonged treatment of HIV-1 infection with a five-drug regimen.
Antiviral therapy 2002;7(1):37-41.
2002: Ronald P van Rij; Janny A Visser; Rieneke van Praag; Ronald Rientsma; Jan M Prins; Joep M A Lange; Hanneke Schuitemaker
Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.
Journal of virology 2002;76(6):3054-8.
2002: Rieneke van Praag; Elisabeth C M van Weert; Rolf P G van Heeswijk; Xiao-Jian Zhou; Jean-Pierre Sommadossi; Suzanne Jurriaans; Joep M A Lange; Richard Hoetelmans; Jan M Prins
Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapy.
Antimicrobial agents and chemotherapy 2002;46(3):896-9.
2002: Wilhelmina E M Schouten; Marjolein Damen; Paul H P Davids; Ruud J Van Ketel; Jan M Prins
Cryptococcal breast abscess.
Scandinavian journal of infectious diseases 2002;34(4):309-10.
2001: Rieneke van Praag; Rolf P G van Heeswijk; Suzanne Jurriaans; Joep M A Lange; Richard Hoetelmans; Jan M Prins
Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(8):e91-2.
2001: Rieneke van Praag; Sjoerd Repping; Jan W A de Vries; Joep M A Lange; Richard Hoetelmans; Jan M Prins
Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma.
Antimicrobial agents and chemotherapy 2001;45(10):2902-7.
2001: Stefan Kostense; Frank M Raaphorst; Jeanine Joling; Daan W Notermans; Jan M Prins; Sven A Danner; Peter Reiss; Joep M A Lange; Judy M Teale; Frank Miedema
T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy.
AIDS (London, England) 2001;15(9):1097-107.
2001: Rieneke van Praag; Jan M Prins; Marijke Th L Roos; P T A Schellekens; Ineke J M ten Berge; Si-La Yong; Hanneke Schuitemaker; A J Eerenberg; Suzanne Jurriaans; Frank de Wolf; C H Fox; Jaap Goudsmit; F Miedema; Joep M A Lange
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.
Journal of clinical immunology 2001;21(3):218-26.
2001: Roelien H Enting; Jan M Prins; Suzanne Jurriaans; K Brinkman; Peter Portegies; Joep M A Lange
Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(7):1095-9.
2000: H Putter; Jan M Prins; Suzanne Jurriaans; M Roos; N M Ferguson; Rieneke van Praag; Lia van der Hoek; Hanneke Schuitemaker; R M Anderson; Jaap Goudsmit; Joep M A Lange; Frank de Wolf
Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection.
AIDS (London, England) 2000;14(18):2831-9.
2000: EH Gisolf; Rieneke van Praag; Suzanne Jurriaans; Peter Portegies; Jaap Goudsmit; Sven A Danner; Joep M A Lange; Jan M Prins
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2000;25(5):426-33.
2000: Dariusz P Olszyna; S M Opal; Jan M Prins; DL Horn; Peter Speelman; Sander J H van Deventer; Tom van der Poll
Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis.
The Journal of infectious diseases 2000;182(6):1731-7.
2000: Daan W Notermans; Frank de Wolf; P Oudshoorn; H T Cuijpers; M Pirillo; F W Tiller; D R McClernon; Jan M Prins; Joep M A Lange; Sven A Danner; Jaap Goudsmit; Suzanne Jurriaans
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations.
AIDS research and human retroviruses 2000;16(15):1507-17.
2000: Jan M Prins; J F Nellen; R P Koopmans; Pim N J Langendijk; Patrick Bossuyt; Peter Speelman
Electronic drug ordering system can be helpful to implement iv-oral switch guidelines.
The Journal of antimicrobial chemotherapy 2000;46(3):518-9.
2000: Fanny N Lauw; AJ Simpson; C Erik Hack; Jan M Prins; Angela M Wolbink; Sander J H van Deventer; W Chaowagul; Nicholas J White; Tom van der Poll
Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria.
The Journal of infectious diseases 2000;182(1):206-13.
2000: Fanny N Lauw; AJ Simpson; Jan M Prins; Sander J H van Deventer; W Chaowagul; Nicholas J White; Tom van der Poll
The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis.
Infection and immunity 2000;68(7):3888-93.
2000: Rieneke van Praag; Gerrit Jan Weverling; Peter Portegies; Suzanne Jurriaans; X J Zhou; M L Turner-Foisy; Jean-Pierre Sommadossi; David Burger; Joep M A Lange; Richard Hoetelmans; Jan M Prins
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir.
AIDS (London, England) 2000;14(9):1187-94.
1999: Jan M Prins; Suzanne Jurriaans; Rieneke van Praag; H Blaak; Ronald P van Rij; P T A Schellekens; Ineke J M ten Berge; Si-La Yong; C H Fox; Marijke Th L Roos; Frank de Wolf; Jaap Goudsmit; Hanneke Schuitemaker; Joep M A Lange
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.
AIDS (London, England) 1999;13(17):2405-10.
1999: Fanny N Lauw; AJ Simpson; Jan M Prins; M D Smith; M Kurimoto; Sander J H van Deventer; Peter Speelman; W Chaowagul; Nicholas J White; Tom van der Poll
Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis.
The Journal of infectious diseases 1999;180(6):1878-85.
1999: F Sevinç; Jan M Prins; R P Koopmans; Pim N J Langendijk; Jacob Dankert; Peter Speelman
[Early change from intravenous to oral antibiotics: 'switch therapy'].
Nederlands tijdschrift voor geneeskunde 1999;143(47):2364-9.
1999: Dariusz P Olszyna; Jan M Prins; Pascale E P Dekkers; Evert de Jonge; Peter Speelman; Sander J H van Deventer; Tom van der Poll
Sequential measurements of chemokines in urosepsis and experimental endotoxemia.
Journal of clinical immunology 1999;19(6):399-405.
1999: F Sevinç; Jan M Prins; R P Koopmans; Pim N J Langendijk; Patrick Bossuyt; Jacob Dankert; Peter Speelman
Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital.
The Journal of antimicrobial chemotherapy 1999;43(4):601-6.
1998: Jan M Prins; Fanny N Lauw; B H F Derkx; Peter Speelman; Ed J Kuijper; Jacob Dankert; Sander J H van Deventer
Endotoxin release and cytokine production in acute and chronic meningococcaemia.
Clinical and experimental immunology 1998;114(2):215-9.
1998: Dariusz P Olszyna; Jan M Prins; B Buis; Sander J H van Deventer; Peter Speelman; Tom van der Poll
Levels of inhibitors of tumor necrosis factor alpha and interleukin 1beta in urine and sera of patients with urosepsis.
Infection and immunity 1998;66(8):3527-34.
1998: Gerrit Jan Weverling; Joep M A Lange; Suzanne Jurriaans; Jan M Prins; Vladimir V Lukashov; Daan W Notermans; M Roos; Hanneke Schuitemaker; Richard Hoetelmans; Sven A Danner; Jaap Goudsmit; Frank de Wolf
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.
AIDS (London, England) 1998;12(11):F117-22.
1998: Jan M Prins; P T A Schellekens; P Reiss
Continued therapy with HIV-1 protease inhibitors, despite previous hypersensitivity reactions, through coadministration of prednisone.
Scandinavian journal of infectious diseases 1998;30(6):612-3.
1998: Jan M Prins; P Speelman
Once-daily aminoglycosides: practical guidelines.
The Netherlands journal of medicine 1998;52(1):1-9.
1997: Jan M Prins; Gerrit Jan Weverling; Ruud J Van Ketel; Peter Speelman
Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
Clinical pharmacology and therapeutics 1997;62(1):106-11.
1997: Jan M Prins; Peter Speelman; Ed J Kuijper; Jacob Dankert; Sander J H van Deventer
No increase in endotoxin release during antibiotic killing of meningococci.
The Journal of antimicrobial chemotherapy 1997;39(1):13-8.
1995: Jan M Prins; M A van Agtmael; E J Kuijper; Sander J H van Deventer; Peter Speelman
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime.
The Journal of infectious diseases 1995;172(3):886-91.
1995: Jan M Prins; R P Koopmans; H R Büller; Ed J Kuijper; Peter Speelman
Easier monitoring of aminoglycoside therapy with once-daily dosing schedules.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1995;14(6):531-5.
1995: Rinze A Tange; Wouter A Dreschler; Jan M Prins; H R Büller; Ed J Kuijper; Peter Speelman
Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial.
Clinical otolaryngology and allied sciences 1995;20(2):118-23.
1994: Jan M Prins; H R Büller; Ed J Kuijper; Rinze A Tange; Peter Speelman
Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial.
The Journal of antimicrobial chemotherapy 1994;33(4):823-35.